Psychostimulant-related deaths among former inmates

Journal of Addiction Medicine

Volumn 6, Issue 2, 2012, Pages 97-105

  Calcaterra, Susan ^a,b,c   Blatchford, Patrick ^d   Friedmann, Peter D ^e,f,g,h   Binswanger, Ingrid A ^a,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Colorado Health Outcomes Program ^*  (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

^d Food Science and Human Nutrition   (United States)

^e Center on Systems Outcomes and Quality in Chronic Disease and Rehabilitation   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g RHODE ISLAND HOSPITAL   (United States)

^h BROWN UNIVERSITY   (United States)

Author keywords

Methamphetamine; Overdose; Prison

Indexed keywords

COCAINE; PSYCHOSTIMULANT AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BEHAVIOR DISORDER; BRAIN HEMORRHAGE; BRAIN HYPOXIA; CAUSE OF DEATH; COCAINE DEPENDENCE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG FATALITY; FEMALE; HEART ARREST; HUMAN; INCARCERATION LENGTH; INTERNATIONAL CLASSIFICATION OF DISEASES; INTOXICATION; LEGAL ASPECT; MALE; MULTIPLE DRUG ABUSE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRISONER; RETROSPECTIVE STUDY; RISK FACTOR; SUBARACHNOID HEMORRHAGE;

ADULT; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COHORT STUDIES; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; PRISONERS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; SURVIVAL ANALYSIS; WASHINGTON;

EID: 84863662336     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e318239c30a     Document Type: Article

References (67)

1. Alaraj A, Wallace A, Mander N, Aletich V, Charbel FT, Amin-Hanjani S. Effect of acute cocaine use on vasospasm and outcome in aneurysmal subarachnoid hemorrhage. World Neurosurg 2010;73(4):357-360.
2. Arria A, Caldeira K, O'Grady K, Vincent K, Johnson E, Wish E. Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy 2008;28:156-169.
3. Bashour T. Acute myocardial infarction resulting from amphetamine abuse: a spasm-thrombus interplay? Am Heart J 1994;128:1237-1239.
4. Bell J, Trinh L, Butler B, Randall D, Rubin G. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction 2009;104(7):1193-1200.
5. Binswanger IA, Blatchford P, Lindsay R, Stern M. Risk factors for all-cause, overdose and early deaths after release from prison in Washington state. Drug Alcohol Depend 2011. doi:10.1016/j.drugalcdep. 2010.11.029
6. Binswanger IA, Stern M, Deyo R, Heagerty P, Cheadle A, Elmore J, et al. Release from prison-a high risk of death among former inmates. N Engl J Med 2007;356;2:157-165.
7. Bureau of Justice Statistics. Number of state prisoners declined by almost 3, 000 during 2009; federal prison population increased by 6, 800. Justice Programs. Press Release June 23, 2010. Available at: http://bjs.ojp. usdoj.gov/content/pub/press/pim09stpy09acpr.cfm. Accessed January 10, 2011.
8. Centers for Disease Control and Prevention. Issue Brief: Unintentional Drug Poisoning in the United States. 2010. Available at: http://www.cdc.gov/ HomeandRecreationalSafety/pdf/poison-issue-brief.pdf. Accessed January 10, 2010.
9. Centers for Disease Control and Prevention. Wonder Database. Available at: http://wonder.cdc.gov/. Accessed March 4, 2009
10. Costa G, Pizzi C, Bresciani B, Tumscitz C, Gentile M, Bugiardini R. Acute myocardial infarction caused by amphetamines: a case report and review of the literature. Ital Heart J 2001;2(6):478-480.
11. Darke S, Kaye S, McKetin R, Duflou J. Major physical and physiological harms of methamphetamine use. Drug Alcohol Rev 2008;27:253-262.
12. Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend 2009;105(1-2):9-15. Epub July 15, 2009.
13. DeSantis A, Webb E, Noar S. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach. J Am Coll Health 2008;57(3):315-324.
14. Diercks D, Fonarow G, Kirk J, Jois-Bilowich P, Hollander J, Weber J, et al. Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the acute decompensated heart failure national registry emergency module). Am J Cardiol 2008;102:1216-1219.
15. Diercks D, Kirk J, Turnipseed S, Amsterdam E. Evaluation of patients with methamphetamine-and cocaine-related chest pain in a chest pain observation unit. Crit Pathways Cardiol 2007;6:161-164.
16. Dupont R, Colemann J, Bucher R, Wilford B. Characteristics and motives of college students who engage in nonmedical use of methylphenidate. Am J Addict 2008;17(3):167-171.
17. Farnsworth T, Brugger C, Malters P. Myocardial infarction after intranasal methamphetamine. Am J Health-Syst Pharm 1997;586-587.
18. Farrell M, Marsden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 2008;103(2):251-255.
19. Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction 2006;101:181-191.
20. French AL, Gawel SH, Hershow R, et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr 2009;51(4):399-406.
21. Glasner-Edwards S, Marinelli-Casey P, Hillhouse M, et al. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow up. J Nerv Men Dis 2009;197(4):225-231.
22. Glaze L, Bonczar T. Bureau of Justice Statistics. Bulletin: Probation and Parole in the United States, 2008. U. S. Department of Justice. Office of Justice Programs. 2009. NCJ 228230. http://bjs.ojp. usdoj.gov/content/pub/pdf/ ppus08.pdf. Accessed February 10, 2010.
23. Harding-Pink D. Mortality following release from prison. Med Sci Law 1990;30(1):12-16.
24. Ho E, Josephson S, Lee H, Smith W. Cerebrovascular complications of methamphetamine abuse. Neurocrit Care 2009;10(3):295-305.
25. Hunt D. Methamphetamine Abuse: Challenges for Law Enforcement and Communities. Natl Inst Justice 2006;254:24-27.
26. HSA Treatment Episode Data Sets (TEDS). 2007. http://oas.samhsa.gov/ nsduh/2k7nsduh/2k7results.cfm#5.8. Accessed November 20, 2010.
27. Iritani B, Hallfors D, Bauer D. Crystal Methamphetamine use among young adult in the USA. Addiction 2007;102(7):1102-1113.
28. Kariminia A, Law M, Butler T, Levy M, Corben S, Kaldor J, et al. Suicide risk among recently released prisoners in New South Wales, Australia. Med J Aust 2007;187(7):387-390.
29. Kaye S, Darke S, Duflou J. (MDMA)-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology. Drug Alcohol Depend 2009; (3) 104:254-261.
30. Kaye S, McKetin R, Duflou J, Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007;102:1204-1211.
31. Klein-Schwartz W. Abuse and toxicity of methylphenidate. Curr Opin Pediatr 2002;14(2):219-223.
32. Kuo CJ, Liao YT, Chen W, et al. Causes of death of patients with methamphetamine dependence: a record-linkage study. Drug Alcohol Rev 2010. doi: 10.1111/j.1465-3362.2010.00255.x.
33. Lejckova P, Mravcik V. Mortality of hospitalized drug users in the Czech Republic. J Drug Issues 2007;37:103-118.
34. Maury E, Darondel Buisinne A, Guitton C, Offenstadt G. Acute pulmonary edema following amphetamine ingestion. Intensive Care Med 1999;25(3):332-333.
35. McGee S, McGee D, McGee M. Spontaneous intracerebral hemorrhage related to methamphetamine abuse. Am J Forensic Med Path 2004;25(4):334-337.
36. McIntosh A, Hungs M, Kostanian V, Yu W. Carotid artery dissection and middle cerebral artery stroke following methamphetamine use. Neurology 2006;67:2259-2260.
37. Møller LF, Matic S, van den Bergh BJ, et al. Acute drug-related mortality of people recently released from prisons. Public Health 2010;124:637-639.
38. Mumola C, Karberg J. Bureau of Justice Statistics Special Report. Drug Use and Dependence, State and Federal Prisoners, 2004. 2006. NCJ 213530. http://bjs.ojp. usdoj.gov/content/pub/pdf/dudsfp04.pdf. Accessed February 13, 2010.
39. Bilgrad R. National Death Index Plus. Coded causes of death. Supplement to the National Death Index user's manual. Hyattsville, MD: National Center for Health Statistics; 1999.
40. Centers for disease Control and Prevention. National Death Index user's manual. Hyattsville, MD: National Center for Health Statistics, 2000.
41. National Evaluation Data and Assistance Center (NEDTAC). Epidemiology and Treatment of Methamphetamine Abuse in California: A Regional Report. 1998. http://www.icpsr.umich.edu/SAMHDA/NTIES/NTIES-PDF/REPORTS/epidmlgy.pdf. Accessed February 13, 2010.
42. Nestor T, Tamamoto W, Kam T, Schultz T. Acute pulmonary oedema caused by crystalline methamphetamine. Lancet 1989;25:2(8674):1277-1278.
43. Ohta K, Mori M, Yoritaka A, Okamoto K, Kishida S. Delayed ischemic stroke associated with methamphetamine use. J Emerg Med 2005;28(2):165-167.
44. O'Neil ML, Kuczenski R, Segal DS, Cho AK, Lacan G, Melega WP. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge. Synapse 2006;60(6):465-73.
45. Packe G, Garton M, Jennings K. Acute myocardial infarction caused by intravenous amphetamine abuse. Br Heart J 1990;64:23-24.
46. Pitts WR, Lange RA, Cigarroa JE, Hillis LD. Cocaine-induced myocardial ischemia and infarction: pathophysiology, recognition, and management. Prog Cardiovasc Dis 1997;40(1):65-76.
47. Ravndal E, Amundsen EJ. Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study. Drug Alcohol Depend 2010;108(1-2):65-69.
48. Reding N. Methland-The Death and Life of an American Small Town. New York: Bloomsbury; 2009.
49. Salo R, Flower K, Kielstein A, et al. Psychiatric comorbidity in methamphetamine dependence. Psychiatry Res 2010. doi:10.1016/j. psychres.2010.09.014.
50. Schifano FA. Bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology 2004;173(3-4):242-248.
51. Schifano F, Corkery J, Deluca P, Oyefeso A, Ghodse AH. Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and death in the UK (1994-2003). J Psychopharmacol 2006; (3): 456-463.
52. Schifano F, Corkery J, Naidoo V, Oyefeso A, Ghodse H. Overview of amphetamine-type stimulant mortality data-UK, 1997-2007. Neuropsychobiology 2010;61(3):122-130.
53. Schwartz B, Rezkalla S, Kloner R. Cardiovascular effects of cocaine. Circulation 2010;122(24):2558-2569.
54. Tobin K, Sherman S, Beilenson P, Welsh C, Latkin C. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy 2009;20(2):131-136. Epub April 22, 2008.
55. Treatment Episode Data Set: The TEDS Report. Trends in Methamphetamine Admission to Treatment: 1997-2007. Available at: http://oas.samhsa.gov/2k9/209/ 209MethTrends2k9-web.pdf. Accessed December 10, 2010.
56. Turnipseed S, Richards J, Kirk J, Diercks D, Amsterdam E. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med 2003;24(4):369-373.
57. U. S. Drug Enforcement Administration. Methamphetamine. 2010. Available at: http://www.justice.gov/dea/concern/meth.html. Accessed...
58. Washington State Department of Corrections. Offender Life-Substance Abuse Treatment. Available at: http://www.doc.wa.gov/family/offenderlife/ substanceabuse.asp. Accessed March 14, 2011.
59. Westover A, McBride S, Haley R. Stroke in young adults who abuse amphetamines or cocaine. Arch Gen Psychiatry 2007;64:495-502.
60. Westover A, Nakonezny P, Haley R. Acute myocardial infarction in young adults who abuse amphetamines. Drug Alcohol Depend 2008;96; 49-56.
61. Wijetunga M, Seto T, Lindsay J, Schatz I. Crystal methamphetamine- associated cardiomyopathy: tip of the iceberg? J Toxicol 2003;41(7):981-986.
62. Wood D, Dargan P, Hoffman R. Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction. Clin Toxicol (Phila) 2009;47(1):14-23.
63. World Health Organization. International Classification of Disease. 2010. Available at: http://www.who.int/classifications/icd/en/. Accessed March 16, 2011.
64. Vlahov D, Wang C, Ompad D, et al. Collaborative Injection Drug User Study. Mortality risk among recent-onset injection drug users in five U. S. cities. Subst Use Misuse 2008;43(3-4):413-428.
65. Xue L, Ko MC, Tong M, et al. Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine. Mol Pharmacol 2011;79(2):290-297. Epub 2010 Oct. 22.
66. Yen CF, Chong MY. Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study. Compr Psychiatry 2006;47:215-220.
67. Yeo K, Wijetunga M, Ito H, Efird J, et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J of Med 2007;120:165-171.